4.7 Article

Transcriptomic profiling of peroxisome-related genes reveals a novel prognostic signature in hepatocellular carcinoma

期刊

GENES & DISEASES
卷 9, 期 1, 页码 116-127

出版社

KEAI PUBLISHING LTD
DOI: 10.1016/j.gendis.2020.04.010

关键词

Gene signature; Hepatocellular; carcinoma; Nomogram; Peroxisome; Prognosis

资金

  1. Ministry of Science and Technology of the People's Republic of China [2017ZX10203202-004-005]

向作者/读者索取更多资源

A novel peroxisome-related gene signature was identified for predicting overall survival in hepatocellular carcinoma patients, showing good prognostic performance. The signature was validated and found to be independently predictive of patient outcomes, suggesting its potential for improving personalized OS prediction in HCC.
Emerging evidence suggests that peroxisomes play a role in the regulation of tumorigenesis and cancer progression. However, the prognostic value of peroxisome-related genes has been rarely investigated. This study aimed to establish a peroxisome-related gene signature for overall survival (OS) prediction in patients with hepatocellular carcinoma (HCC). First, univariate Cox regression analysis was employed to identify prognostic peroxisome-related genes in The Cancer Genome Atlas liver cancer cohort, and least absolute shrinkage and selection operator Cox regression analysis was used to construct a 10-gene signature. The risk score based on the signature was positively correlated with poor prognosis (HR = 4.501, 95% CI = 3.021-6.705, P = 1.39e-13). Second, multivariate Cox regression incorporating additional characteristics revealed that the signature was an independent predictor. Time-dependent ROC curves demonstrated good performance of the signature in predicting the OS of HCC patients. The prognostic performance was validated using International Cancer Genome Consortium HCC cohort data. Gene set enrichment analysis revealed that the signature-related alterations in biological processes mainly involved peroxisomal functions. Finally, we developed a nomogram model based on the gene signature and TNM stage, which showed a superior prognostic power (C-index = 0.702). Thus, our study revealed a novel peroxisome-related gene signature that may help improve personalized OS prediction in HCC patients. Copyright (C) 2020, Chongqing Medical University. Production and hosting by Elsevier B.V.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据